You are here

Docket Number 3359

Received: 
Wednesday, January 30, 2019
Commodity: 
Botulinum Toxin Products
Investigation Number: 
337-TA-1145
Filed By: 
Brian M. Buroker
Firm/Organization: 
Gibson, Dunn & Crutcher LLP
Behalf Of: 
Medytox Inc., Allergan PLC and Allergan, Inc.
Confidential: 
Yes
Country: 
None
Description: 
Letter to Lisa R. Barton, Secretary, USITC; requesting that the Commission conduct an investigation under section 337 of the Tariff Act of 1930, as amended, regarding Certain Botulinum Toxin Products, Processes for Manufacturing or Relating to Same and Certain Products Containing Same. The proposed respondents are Daewoong Pharmaceuticals Co., Ltd., South Korea; Daewood Co., Ltd., South Korea and Evolus, Inc., Irvine, CA.